Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Analysis

Editor-in-Chief

ISSN (Print): 1573-4129
ISSN (Online): 1875-676X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development of Acid-Neutralization and In Vitro Dissolution to Evaluate the Overall Quality of Compound Aluminum Hydroxide Tablets

Author(s): Yuqing Yang, Yuling Zhong, Tingting Xie and Mengxiang Su*

Volume 18, Issue 5, 2022

Published on: 26 August, 2021

Page: [542 - 552] Pages: 11

DOI: 10.2174/1573412917666210826144421

Price: $65

Abstract

Background: Compound Aluminum Hydroxide Tablets (CAHTs) are widely used in the Chinese domestic market, and strict quality control is required to ensure their clinical efficacy.

Purpose: In this study, we established a comprehensive strategy of acid-neutralization, in vitro dissolution and an assay of magnesium trisilicate to evaluate the overall quality and monitor the consistency of CAHTs.

Methods: The acid-neutralization profiles of 38 batches of CAHTs were generated using the dissolution and release method III (the cup method, the Chinese pharmacopeia) combined with potentiometric titration. To directly reflect the disintegration and release process of the preparation, we optimized the sample pretreatment method by omitting the grinding step to determine the profiles of complete tablets. In addition, in vitro dissolution was conducted in the hydrochloric acid medium at pH 1.0 by using the assay of magnesium trisilicate through a validated approach of Flame Atomic Absorption Spectrophotometry (FAAS) to evaluate the similarity of the dissolution profiles.

Results: Acid-neutralization tests showed that the quality of the samples from manufacturers B and F was poor. In vitro dissolution experiments showed that the samples from manufacturer A had the highest similarity with the reference preparation, which indicated their good quality consistency. Besides, the optimized acid-neutralization method had the advantage of simple operation and enabled direct characterization of pharmacodynamics in the quality consistency evaluation of antacids.

Conclusion: A successful synthetic evaluation strategy was established to assess the overall quality of CAHTs, which demonstrated that the improvement in the quality of this formulation is imperative.

Keywords: Compound aluminium hydroxide tablet, quality evaluation, acid-neutralization, in vitro dissolution, ƒ2 similarity factor, flame atomic absorption spectrophotometry.

« Previous Next »
Graphical Abstract

[1]
Macke, L.; Schulz, C.; Koletzko, L.; Malfertheiner, P. Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies. Aliment. Pharmacol. Ther., 2020, 51(5), 505-526.
[http://dx.doi.org/10.1111/apt.15604] [PMID: 31990420]
[2]
Flamm, S.; Reddy, K.R.; Zadeikis, N.; Hassanein, T.; Bacon, B.R.; Maieron, A.; Zeuzem, S.; Bourliere, M.; Calleja, J.L.; Kosloski, M.P.; Oberoi, R.K.; Lin, C.W.; Yu, Y.; Lovell, S.; Semizarov, D.; Mensa, F.J. Efficacy and pharmacokinetics of glecaprevir and pibrentasvir with concurrent use of acid-reducing agents in patients with chronic hcv infection. Clin. Gastroenterol. Hepatol., 2019, 17(3), 527-535.e6.
[http://dx.doi.org/10.1016/j.cgh.2018.07.003] [PMID: 30012435]
[3]
Rodríguez-Fuentes, G.; Denis, A.R.; Álvarez, M.A.B.; Colarte, A.I. Antacid drug based on purified natural clinoptilolite. Microporous Mesoporous Mater., 2006, 94(1-3), 200-207.
[http://dx.doi.org/10.1016/j.micromeso.2006.03.032]
[4]
Hydrotalcite tablets. British Pharmacopoeia; Medicines and Healthcare products Regulatory Agency (MHRA): London, UK, 2021, III,.
[5]
General chapter 301, acid-neutralizing capacity. USP 43-NF 38; The United States Pharmacopeial Convention: Rockville, MD, USA, 2020.
[6]
Compound aluminium hydroxide tablets. Chinese pharmacopoeia; Pharmacopoeia Committee of P. R. China: Beijing, China, 2020, II, p. 974.
[7]
Shen, Z.; Liang, Z.M. [Studies on the physical structure and pharmaceutical properties of aluminum hydroxide tablets Yao Xue Xue Bao, 1984, 19(11), 842-848.
[PMID: 6544552]
[8]
Liu, T.; Yang, Y.; Wu, Y.; Yu, X.; Liu, L.; Bai, Z. Study on neutralising speed of hydrotalcite tablets and hydrotalcite chewable tablets. Yaowu Fenxi Zazhi, 2017, 37, 2087-2092.
[9]
Liu, T.; Yu, X.; Xun, Y.; Liu, L.; Wang, F.; Bai, Z.; Zhang, Q.; Zhang, Q.; An, H. Critical quality attributes, quality metrics and quality evaluation of antacids. Drug Stand China, 2017, 18, 13-15.
[10]
Armstrong, J.; Martin, M. An in vitro evaluation of commonly used antacids with special reference to aluminium hydroxide gel and dried aluminium hydroxide gel. J. Pharm. Pharmacol., 1953, 5(10), 672-685.
[PMID: 13097358]
[11]
General chapter <9101>, guidelines for validation of analytical methods of pharmaceutical quality standards, chinese pharmacopoeia; Pharmacopoeia Committee of P. R.: Beijing, China, 2020.
[12]
Center for Drug Evaluation, NMPA, China. Determination and comparison of dissolution profiles for common oral solid preparations. 2016. Available from: http://www.cde.org.cn/news.do?method=viewInfo [Cited 2020 Dec 16]
[13]
Diaz, D.A.; Colgan, S.T.; Langer, C.S.; Bandi, N.T.; Likar, M.D.; Van Alstine, L. Dissolution similarity requirements: how similar or dissimilar are the global regulatory expectations? AAPS J., 2016, 18(1), 15-22.
[http://dx.doi.org/10.1208/s12248-015-9830-9] [PMID: 26428517]
[14]
Soni, T.G.; Desai, J.U.; Nagda, C.D.; Gandhi, T.R.; Chotai, N.P. Mathematical evaluation of similarity factor using various weighing approaches on aceclofenac marketed formulations by model-independent method. Pharmazie, 2008, 63(1), 31-34.
[PMID: 18271300]
[15]
Costa, P. An alternative method to the evaluation of similarity factor in dissolution testing. Int. J. Pharm., 2001, 220(1-2), 77-83.
[http://dx.doi.org/10.1016/S0378-5173(01)00651-2] [PMID: 11376969]
[16]
Xie, F.; Ji, S.; Cheng, Z. In vitro dissolution similarity factor (f2) and in vivo bioequivalence criteria, how and when do they match? Using a BCS class II drug as a simulation example. Eur. J. Pharm. Sci., 2015, 66, 163-172.
[http://dx.doi.org/10.1016/j.ejps.2014.10.002] [PMID: 25315411]
[17]
Center for Drug Evaluation, NMPA, China. Evaluation Suggestions for Domestic Unique Varieties. 2019. Available from: http://www.cde.org.cn/news.do?method=viewInfoCommon&id=4f87024207c8fc69 [Cited 2020 Dec 16].
[18]
Ayensu, I.; Bekoe, S.O.; Adu, J.K.; Brobbey, A.A.; Appiah, E. Evaluation of acid neutralising and buffering capacities of selected antacids. Ghana. Sci Afr, 2020, 8, 1-7.
[19]
Kerkhof, N.J.; Vanderlaan, R.K.; White, J.L.; Hem, S.L. pH-stat titration of aluminum hydroxide gel. J. Pharm. Sci., 1977, 66(11), 1528-1533.
[http://dx.doi.org/10.1002/jps.2600661106] [PMID: 21278]
[20]
General chapter <0923>, guidelines for validation of analytical methods of pharmaceutical quality standards, chinese pharmacopoeia; Pharmacopoeia Committee of P.R.: Beijing, China, 2020.

Rights & Permissions Print Cite
Article Metrics
27
1
© 2024 Bentham Science Publishers | Privacy Policy